Matt Hancock giving Downing Street coronavirus press briefing

The transcript discusses the UK government's request for the MHRA to assess the Pfizer Biontech vaccine for authorization. The MHRA, known for its independence, is already receiving data from Pfizer. If approved, the vaccine will be distributed across the UK, prioritizing those at greatest risk. The NHS will manage the logistical challenges, leveraging its experience with the annual flu vaccine program.

What criteria will be used to prioritize groups for vaccination?

What challenges are anticipated in the rollout of the vaccine?